Dotzon-S Injection
Marketer
Dote Health Care
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Dotzon-S Injection
Injectible Dotzon-S is a multi-component medication indicated for diverse bacterial infections. Its action combats microbial proliferation, thus limiting infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; treatment should be completed fully, irrespective of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Significant worsening of any side effect mandates immediate medical consultation. Allergic reactions (such as rashes, pruritus, edema, or dyspnea) necessitate urgent medical attention. Prior to commencing treatment, disclose all current medications and health conditions to your physician. This is particularly important for pregnant or lactating individuals. Alcohol consumption should be avoided due to the potential for increased somnolence. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood work and other tests to monitor the medication's effects.
Primary Ingredients of Dotzon-S Injection
No information provided. A rewritten text cannot be provided.
Uses of Dotzon-S Injection
Managing bacterial illnesses
Major Benefits of Dotzon-S Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Dotzon-S Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Dotzon-S Injection:
Administering this medication will be done by your physician or their assistant; self-medication is strongly discouraged.
How Dotzon-S Injection works:
Dotzon-S Injection contains Cefoperazone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Sulbactam augments Cefoperazone's effectiveness by counteracting bacterial enzymes that would otherwise inactivate it.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Dotzon-S Injection treatment can lead to adverse effects including facial redness, rapid pulse, queasiness, dehydration, thoracic discomfort, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injection, Dotzon-S, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Dotzon-S Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Dotzon-S Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Dotzon-S Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Dotzon-S Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Dotzon-S Injection :
Omit a Dotzon-S Injection dose? Seek medical advice immediately.
Facts to Know About Dotzon-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |

